SPACE - A randomized study of SBRT
vs conventional fractionated radiotherapy
in medically inoperable stage I NSCLC
J. Nyman et al. world lung 2015
102 patients,
(T1-2N0M0) NSCLC,
significant comorbidity
9 Scandinavian centers
rando:
SBRT 3x 22 Gy;
CFRT 35x 2 Gy
primary endpoint:
freedom from progression
at 3 years
11 · 1. Oktober 2018